What are the Historical Developments and Current Growth Metrics of the Virology And Bacteriology Market?
The virology and bacteriology market has seen considerable growth due to a variety of factors.
• The market size for virology and bacteriology has significantly expanded in the past few years. It is expected to rise from $2.44 $ billion in 2024 to $2.67 $ billion in 2025, boasting a compound annual growth rate (CAGR) of 9.5%.
The historical growth is due to factors such as increased global travel, a higher demand for quick diagnostic tests, the rise of globalization, advancements in research on zoonotic diseases, and the expansion of educational programs.
What is the Forecasted Market Size and CAGR for the Virology And Bacteriology Market?
The virology and bacteriology market is expected to maintain its strong growth trajectory in upcoming years.
• The market size of virology and bacteriology is anticipated to experience significant expansion in the coming years. The market is predicted to burgeon to $3.78 billion by 2029, growing at a compound annual growth rate (CAGR) of 9.1%.
Such robust growth projection for the forecast period is a result of the escalating incidences of infectious diseases, expansion of healthcare infrastructure worldwide, increased research activities, surge in disposable income, and a rising volume of aerobic and anaerobic tests. The future trend predictions entail technological progress, personalized healthcare, incorporation of artificial intelligence, advancements in vaccine technology, and the rise of telemedicine.
What Key Factors and Trends Are Driving The Growth Virology And Bacteriology Market?
The surge in instances of infectious diseases is anticipated to fuel the expansion of the virology and bacteriology market. Infectious diseases are disorders induced by harmful microorganisms such as bacteria, viruses, fungi, or parasites that infect and proliferate inside the body. Some of these communicable diseases encompass influenza, tuberculosis (TB), HIV/AIDS, malaria, and so on. The escalating prevalence of infectious diseases can be attributed to the increasing threats presented by pathogens, potentially due to elements like globalization, urbanization, antimicrobial resistance, and shifts in the environment. Virology and bacteriology testing play a vital role in diagnosing these diseases by pinpointing the specific pathogens causing the disease, facilitating specific treatment and management. For instance, as per the Centers for Disease Control and Prevention, a US government organization, in November 2023, the cases of tuberculosis (TB) in the US saw a rise of 5.9% from 7,870 cases in 2021 to 8,331 cases in 2022. Thus, the growing incidence of infectious diseases is poised to stimulate the virology and bacteriology market.
What Are The Market Segments In The Virology And Bacteriology Market?
The virology and bacteriologymarket covered in this report is segmented –
1) By Product: Equipment, Reagents
2) By Technology: Molecular Diagnostics, Immunoassays, Diagnostic Imaging, Information Technology
3) By End User: Hospitals, Diagnostic Centers, Research Laboratories, Blood Banks
Subsegments:
1) Equipment: Laboratory Equipment, Diagnostic Instruments
2) Reagents: Culture Media, Detection Kits
Pre-Book The Virology And Bacteriology Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends Are Reshaping The Future Of The Virology And Bacteriology Market?
Primary businesses in the bacteriology and virology market are honing in on the creation of novel products like bacteria detection kits in order to enhance diagnostic capabilities and tackle the issue of infectious diseases. Bacteria detection kits, diagnostic instruments that detect and analyze bacterial presence in several types of samples such as blood, urine, food, and environmental matter, are now a focal point. As an example, HiMedia Laboratories LLC, an Indian bioscience firm, and NG Biotech, a French in vitro diagnostic device producer, formed a partnership in December 2023. Together, they introduced the NG-Test CARBA 5 kits for locating carbapenemase-producing bacteria which earned approval from the Central Drugs Standard Control Organization (CDSCO). These kits employ cutting-edge technology to precisely identify a wide range of bacteria resistant to antimicrobials, including those generating enzymes like carbapenemases. The kits yield quick and dependable outcomes, enabling swift decision-making in clinical environments. They are crafted for ease of use and can accommodate a diversity of sample types such as blood, urine, and environmental matter.
Who Are the Key Players In The Virology And Bacteriology Market?
Major companies operating in the virology and bacteriology market are:
• F. Hoffmann-La Roche AG
• Merck KGaA
• Thermo Fisher Scientific Inc.
• Abbott Laboratories
• Danaher Corporation
• Siemens Healthineers AG
• Becton Dickinson and Company
• Laboratory Corporation of America Holdings
• Agilent Technologies Inc.
• Hologic Inc.
• bioMérieux SA
• Bio-Rad Laboratories Inc.
• Bruker Corporation
• Cepheid Inc.
• Eiken Chemical Co. Ltd.
• NEOGEN Corporation
• Cerba Research
• Luminex Corporation
• Fujirebio Diagnostics Inc.
• Trinity Biotech plc
• Microbiologics Inc.
• Bionano Genomics Inc.
• Scienion GmbH
• Quidel Corporation
What Are The Regional Insights Into The Virology And Bacteriology Market?
North America was the largest region in the virology and bacteriology market in 2024. The regions covered in the virology and bacteriology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
